Coronary Vasomotor Dysfunction Spasm clinical trials

Explore recruiting coronary vasomotor dysfunction spasm clinical trials.

Also recruiting in Europe

Coronary Vasomotor Dysfunction Spasm trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled clinical trial.

Netherlands

Phase II and Phase III (Integrated) EU CTIS Study details

Coronary Vasomotor Dysfunction Spasm trials by city

Coronary Vasomotor Dysfunction Spasm in Toronto Coronary Vasomotor Dysfunction Spasm in Vancouver Coronary Vasomotor Dysfunction Spasm in Montreal Coronary Vasomotor Dysfunction Spasm in Calgary Coronary Vasomotor Dysfunction Spasm in Edmonton Coronary Vasomotor Dysfunction Spasm in Ottawa Coronary Vasomotor Dysfunction Spasm in Winnipeg Coronary Vasomotor Dysfunction Spasm in Quebec City Coronary Vasomotor Dysfunction Spasm in Hamilton Coronary Vasomotor Dysfunction Spasm in Kitchener Coronary Vasomotor Dysfunction Spasm in London Coronary Vasomotor Dysfunction Spasm in Halifax Coronary Vasomotor Dysfunction Spasm in New York Coronary Vasomotor Dysfunction Spasm in Los Angeles Coronary Vasomotor Dysfunction Spasm in Chicago Coronary Vasomotor Dysfunction Spasm in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease